Skip header and navigation

Refine By

   MORE

11 records – page 1 of 2.

measles vaccine kit

https://mhc.andornot.com/en/permalink/artifact4044
Dates
1968
circa 1968
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001249 a-g
Description
A styrofoam container (a) consisting of two moulded pieces of styrofoam held together by the label; inside are five cylindrical glass ampoules (b-f) with icicle-shaped melted glass seals containing the vaccine and one glass vial (g) stopped with a rubber stopper and sealed with a metal ring around …
  4 images  
Accession Number
000001249 a-g
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Measles -- prevention & control
Measles Vaccine
Vaccination
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- ampoule
Description
A styrofoam container (a) consisting of two moulded pieces of styrofoam held together by the label; inside are five cylindrical glass ampoules (b-f) with icicle-shaped melted glass seals containing the vaccine and one glass vial (g) stopped with a rubber stopper and sealed with a metal ring around the lip containing a diluent.
Number Of Parts
7
Part Names
a - box - Size: Length 13.9 cm x Width 8.3 cm x Depth 3.0 cm
b - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
c - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
d - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
e - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
f - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
g - vial - Size: Length 4.1 cm x Diam. 2.1 cm
Provenance
Collected by Parke-Davis
Maker
Philips Roxane, Inc.
Site Made (City)
St. Joseph
Site Made (State)
Missouri
Site Made (Country)
United States of America
Dates
1968
circa 1968
Date Remarks
Earliest expiry date
Material
styrofoam: white
paper: white; blue; black
glass: clear; blue
rubber: yellow
metal: silver
Inscriptions
(a) Top: "5 DOSES Bio. 49 // MEASLES VIRUS VACCINE, // LIVE, ATTENUATED // C // Contains 5 one-dose ampoules of attenuated Edmonston strain vaccine grown on // tissue cultures of canine renal cells and one 4.5 cc. vial of diluent for preparing solu- // tion for injection. Diluent contains 0.05% methylparaben and 0.005% propylparaben // as preservatives. // Prepare solution for injection by slowly adding 0.7 cc. diluent to contents of // ampoule. Gently agitate and allow a few seconds for the contents to dissolve. // DOSE – A single injection of 0.5 cc. of solution prepared as above, administered // subcutaneously into the upper arm; or subcutaneously or intramuscularly into the // upper, outer quadrant of the buttocks. For coadministration of gamma globulin, // see package insert. // Administration to infants under nine months of age is not recommended. // See package insert for contraindications and precautions. // Expiration Date: [printed] // Oct. 15, 1969 [stamped] // Lot No. [printed] // PD804B [stamped] // Stock 4-49-1-70 // Distributed by // PARKE, DAVIS & CO. DETROIT, MICH., U.S.A."; front: "Each dose contains not less than 1000 TCid50 ["50" subscr.] of measles virus vaccine as compared // to U.S. NIH measles virus reference standard, not more than 33 mcg. dihydrostrep- // tomycin sulfate and 17 units of polymyxin B sulfate. // CUT ON DOTTED LINE // Store at temperature between 2° and 8° C (35.6° and 46.4° F.). // Storage at freezing temperature not required. // Protect vaccine from prolonged exposure to direct sunlight."; back: "Manufactured by // PHILIPS ROXANE, INC. ST JOSEPH, MO., U.S.A. // U.S. Licence 376. Canadian Licence 127"; (b-e) "1 DOSE Bio. 49 // MEASLES VIRUS VACCINE, // LIVE, ATTENUATED // 1000 TCID50 ["50" subscr.] // See insert. // US. Licence 376 // Mfd. by Philips Roxane, Inc. // St. Joseph, Mo., U.S.A. // Dist. by Parke, Davis & Co. // Detroit, Mich., U.S.A.// LOT PD 804B // Exp. )ct. 15-69 [stamped]"; (f) same printed text as (b-e) followed by "LOT PD619-1 // Exp. Aug. 24-68"; (g) "4.5 CC. // DILUENT FOR MEASLES VIRUS // VACCINE, LIVE, ATTENUATED // Mfd. by Philips Roxane, Inc. // St. Joseph, Mo., U.S.A. // Dist. by Parke, Davis & Co. // Detroit, Mich., U.S.A. // Contains 0.05% methylparaben and // 0.005% propylpara- // ben as preservatives. // LOT 7404D [stamped]"
Permanent Location
Storage Room 0010
0010-A3-5 Row B
Temporary Location
On exhibit at City of Ottawa - Public Health L-2016-3 14 Mar 2016 – 31 Dec 2018
Condition Remarks
Label is yellowing, dirty; some dents in styrofoam; labels on ampoules and vial are yellowing.
Copy Type
Original
Exhibit History
May 24 - Sept. 13, 2001: Agnes Etherington Art Centre Museopathy exhibit
Images
Less detail
Dates
1975
circa 1975
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001281 a-c
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
  1 image  
Accession Number
000001281 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1975
circa 1975
Date Remarks
Based on expiry date
Material
glass: clear
paper: white; blue; black
cardboard: white; blue
plastic: blue
metal: silver
rubber: pink
Inscriptions
(a) Front: "5 ML. Bio. 1568 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1973-74 season. // Stock 4-1568-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 1000 CCA units per human dose (0.5 // ml.) in the recommended ratio of 700 CCA units of the A // influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injections // of 0.5 ml. each, given at least two months apart. See // package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propogated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1568 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] Feb. 1, 1975 // 903033B [stamped]"; (b) front: "C // 5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains no less than 1000 CCA units per human dose // (0.5 ml.) in the recommended ratio of 700 CCA units of the A influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – Two // intramuscular injections of 0.5 // ml. each, given at least two months apart. See package // inssert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp Date and Lot [printed] // Feb. 1, 1975 // 903033B [stamped]"; bottom: "W // 83 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "C // FLUOGEN® // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 877800 C-PO // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from DESCRIPTION] // INDICATIONS // [text follows] // 121 877800 2 C - PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from INDICATIONS] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 121 877800 3 C-PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 877800 //Parke, Davis & Co. // Detroit, Mi 48232 USA C-PD // A // Issued Aprile 1973 [French translation appears alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Condition Remarks
Box somewhat dirty, dented; no apparent problems wtih vial or leaflet
Copy Type
Original
Reference Types
Other
JPG
Reference Comments
See also 000.001.282; CD #8
Images
Less detail
Dates
1974
circa 1974
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001282 a-c
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
  1 image  
Accession Number
000001282 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1974
circa 1974
Date Remarks
Based on expiry date
Material
glass: clear
paper: white; blue; black
cardboard: white; blue
plastic: blue
metal: silver
rubber: pink
Inscriptions
(a) Front: "5 ML. Bio. 1568 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1973-74 season. // Stock 4-1568-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 1000 CCA units per human dose (0.5 // ml.) in the recommended ratio of 700 CCA units of the A // influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injections // of 0.5 ml. each, given at least two months apart. See // package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propogated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1568 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] Nov. 15, 1974 // 903028C [stamped]"; (b) front: "C // 5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains no less than 1000 CCA units per human dose // (0.5 ml.) in the recommended ratio of 700 CCA units of the A influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – Two // intramuscular injections of 0.5 // ml. each, given at least two months apart. See package // inssert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp Date and Lot [printed] // Nov. 15, 1974 // 903028C [stamped]"; bottom: "W // 91 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "C // FLUOGEN® // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 877800 C-PO // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from DESCRIPTION] // INDICATIONS // [text follows] // 121 877800 2 C - PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from INDICATIONS] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 121 877800 3 C-PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 877800 //Parke, Davis & Co. // Detroit, Mi 48232 USA C-PD // A // Issued Aprile 1973 [French translation appears alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Condition Remarks
Box somewhat dirty, dented; no apparent problems wtih vial or leaflet
Copy Type
Original
Reference Types
Other
JPG
Reference Comments
See also 000.001.281; CD #8
Images
Less detail

Influenza Virus Vaccine

https://mhc.andornot.com/en/permalink/artifact4076
Dates
1969
circa 1969
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001283 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over vial neck and lip; vial is in a cardboard box (a) with a paper leaflet (c); there is a square white sticker on left side of box
  1 image  
Accession Number
000001283 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over vial neck and lip; vial is in a cardboard box (a) with a paper leaflet (c); there is a square white sticker on left side of box
Number Of Parts
3
Part Names
a - box - Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Length 5.2 cm x Diam. 2.6 cm
c - leaflet (unfolded) - Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis.
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1969
circa 1969
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; red; blue; black
cardboard: white; blue; red; black
rubber: pink
glass: clear
Inscriptions
(a) Front: "10 CC. Bio. 844 // INFLUENZA VIRUS VACCINE, // BIVALENT // C // Contains: A2 //Japan/170/62, A2 // Taiwan/1/64 // and B/Massachusetts/3/66 strains. // BIVALENT // Stock 4-844-1-70 // PARKE-DAVIS"; bottom: "Standardized according to the U.S. Public Health // Service requirements for the 1968-69 season. // Contains 0.01% thymersal (mercury derivative). // Store at temperature between 2° and 8° C. // (35.6° and 46.4° F.). // FREEZING DESTROYS POTENCY"; back: "Prepared from the refined extra-embryonic fluid of // the chick embryo, killed by ultraviolet irradiation // and formalin, and absorbed on aluminum phosphate. // U.S. Licence No. 1 // Canadian Licence no. 1"; top: "SHAKE WELL BEFORE USING // USUAL ADULT DOSE – Two intramuscular injec- // tions of 1 cc. each, given at least two months // apart. See package insert. // Parke, Davis & Company // Detroit, Michigan, U.S.A. 48232"; right side: "10 CC. Bio. 844 // INFLUENZA // VIRUS VACCINE, // BIVALENT // Parke, Davis & Co. // Expiration Date and Lot // NOV 15, 1969 // 985259B"; left side: "10 CC. Bio. 844 // INFLUENZA // VIRUS VACCINE, // B1 [illeg.] // Pa [illeg.] Co. // S [illeg.]"; (b) front: "C 10 CC. Bio. 844 // INFLUENZA VIRUS VACCINE, // BIVALENT // Contains: A2 // Japan/170/62, A2 /Taiwan/64 // and B/Massachusetts/3/66 strains. // Standardized according to the U.S. Public // Health Service requirements for the // 1968-69 season. // BIVALENT // PARKE, DAVIS & CO. DETROIT, Mich., U.S.A."; back: "USUAL ADULT DOSE // Two intramuscular in- // jections of 1 cc. each, // given at least two months // apart. See package // insert. // SHAKE WELL // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Expiration date and Lot // Nov. 15, 1969 // 985259B "; bottom: "NT I // K // 10 // U.S.A."; (c) "C // INFLUENZA VIRUS VACCINE // BIVALENT POLYVALENT // PARKE-DAVIS // Beginning with the 1967-68 season, Influenza Virus // Vaccine is supplied in two formulas: // [text follows] // INDICATIONS // [text follows] // HB // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 2 // HB // [text continues from Adverse Reactions] // ADMINISTRATION AND DOSAGE // [text follows] // 3 // HB // [text continues from Administration] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // PARKE, DAVIS [logo, see sketch on accession sheet] & COMPANY // 121 856750 // K - 97 - A DETROIT, MICHIGAN, U.S.A. HB // Issued Mar. 1968 [French translation accompanies English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Temporary Location
On loan to Museum of Health Care Education Department for Seniors’ Learning Program 22 Aug 2016.
Condition Remarks
Box somewhat yellowed, dented, dirty; leaflet mottled with a yellow stain throughout; no apparent problems with vial
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail

Influenza Virus Vaccine vial

https://mhc.andornot.com/en/permalink/artifact4077
Dates
1981
circa 1981
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001284 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (…
  1 image  
Accession Number
000001284 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1981
circa 1981
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; blue; black
cardboard: white; blue; black
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "DIN 248991 Stock 4-4079-63-70 // INFLUENZA VIRUS VACCINE, // TRIVALENT, TYPES A AND B // FLUOGEN® Subvirion Vaccine // Dose – Persons 27 years and older, a single injection of 0.5 ml; // persons 3 years through 26 years, 2 injections of 0.5 ml, 4 or // more weeks apart; persons 6 months through 35 months, 2 // injections of 0.25 ml, 4 or more weeks apart. Inject // intramuscularly. See package insert. // 5 ml PARKE-DAVIS"; bottom: "Standardized according to 1979-80 NACI and US PHS requirements. // Contains no less than 21 micrograms of HA antigen content per // 0.5 ml dose in the recommended ratio of 7µg of HA of the A // influenza virus component representative of A/Brazil/78 (H1N1), 7 // µg of HA of the A influenza virus component representative of // A/Texas/1/77 (H3N2), and 7µg of HA of the B influenza virus component representative of B/Hong Kong/5/72. The vaccine is of chick embryo origin. // Polysorbate 80, USP, added during manufacture. // Preservative: 0.01% thimer- // osal (mercury derivative). //Store at temperature between // 2° and 8° C (36° and 46° F). // Freezing destroys potency. // Exp date and lot [printed] // FEB. 5, 1981 // YH601 [stamped]"; back: front repeated in French; top: bottom repeated in French up to and including "Freezing destroys potency"] // Permis US n°1 Permis can. n°1 // Parke, Davis & Co/Detroit, Mi 48232 USA"; right side: "5 ml // FLUOGEN // U.S. Lic. No. 1 Can. Lic. No. 1 // PARKE-DAVIS"; left side: "5 ml // FLUOGEN // Stock 4-4079-63-70 // PARKE-DAVIS // Printed in USA // 120 // 457217"; (b) front: "DIN 248991 C // INFLUENZA VIRUS VACCINE, TRIVALENT // TYPES A AND B FLUOGEN® Subvirion // Vaccine // [contents as listed on box front] // The vaccine is of chick embryo origin. // 5 ml PARKE-DAVIS"; back: "LOT YH607 [stamped] // Dose – See package insert. // Standardized according to // the NACI and the US PHS // requirements for the // 1979-80 season. // Stock 4-4079-63-70 // U.S. Lic. No. 1 Can Lic. No. 1 [printed] // EXP FEB. 5, 1981 [stamped] // Parke, Davis & Co // Detroit, Mi 48232 USA // 02 4079 70 1 [printed]"; bottom: "W // 79 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "FLUOGEN® // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // Subvirion Vaccine/Immunizing Antigen, Ether Extracted // DESCRIPTION // [text follows] // ACTION // [text follows] // PARKE-DAVIS // 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Action] // INDICATIONS // 2 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // WARNING // [text follows] // PRECAUTIONS // [text follows] // USAGE IN PREGNANCY // [text follows] // ADVERSE REACTIONS // 3 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Adverse Reactions] // DOSAGE AND ADMINISTRATION // [text follows] // STORAGE // [text follows] // PACKAGE INFORMATION // [text follows] // Unpublished data available upon request. // Issued June 1979 // Parke, Davis & Co., Detroit, Mi 48232 USA 121 887150/C-KF // [French translation accompanies English text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box somewhat yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail
Dates
1975
circa 1975
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001285 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper …
  1 image  
Accession Number
000001285 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Vaccination
Influenza
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1975
circa 1975
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; red; black
cardboard: white; blue; red
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "5 ML. Bio. 1600 // FLUOGEN®-B // Standardized according to the U.S. Public // Health Service requirements for the 1973-74 season. // Stock 4-1600-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // PARKE, DAVIS & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1600 // INFLUENZA VIRUS VACCINE, MONVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 500 CCA units per human dose // (0.5 ml.) of a type B influenza virus strain representative of // B/Hong Kong /5/72. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – One intramuscular injection of // 0.5 ml. See package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propagated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1600 // FLUOGEN®-B // PARKE-DAVIS [printed] // Exp. Date and Lot // Feb. [stamped] 75 [handwritten] // 903619A [stamped] // 120 // 455817 [printed]"; (b) front: "5 ML. Bio. 1600 // INFLUENZA VIRUS VACCINE MONOVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN®-B // Contains no less than 500 CCA units per human // dose (0.5 ml.) of a type B influenza virus strain // representative of B/Hong Kong/5/72. // Parke, Davis & Co/Detroit, Mi 48232 USA C [printed] // USUAL ADULT DOSE – One // intramuscular injection of 0.5 // ml. See package insert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp. Date and Lot [printed] // Feb. 5, 1975 // 903619A [stamped]"; bottom: "W // 88 [embossed]"; top: "FLIP // OFF [embossed]"; (c) FLUOGEN®-B // INFLUENZA VIRUS VACCINE, MONOVALENT // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 878100 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from Description] // INDICATIONS // [text follows] // 121 878100 2 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // 121 878100 2 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // ADVERSE REACTIONS // [text follows] // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 878100 // PARKE, DAVIS & Co // Detroit Mi 48232 USA // A // Issued June 1973 // C-PF // [French translation accompanies English, alongside text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail

influenza virus vaccine vial

https://mhc.andornot.com/en/permalink/artifact4079
Dates
1970
circa 1970
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001286 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is removed, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper lea…
  5 images  
Accession Number
000001286 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is removed, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c); there is a square sticker on the box back.
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 5.2 cm x Diam. 2.6 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1970
circa 1970
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; blue; black
ink: blue; black
cardboard: white; blue
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "10 CC. Bio. 669 // INFLUENZA VIRUS VACCINE, // MONOVALENT // C Contains: A2 ["2" subscr.]/Aichi/2/68 strain // (Hong Kong Variant) // Each 1 cc. contains 400 CCA units. // Stock 4-669-1-70 // PARKE-DAVIS"; bottom: "U.S. Licence No. 1. // Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (35.6° and 46.4° F.). // FREEZING DESTROYS POTENCY"; back: "Prepared from the refined extra-embryonic fluid of // the chick embryo, killed [illeg.] iolet irra- // diation and formalin. A [illeg.] is added // as a [illeg.] // Contains 0.01% thimerosal [illeg.] derivative). [printed] // JA // 2 // WHIT [stamped on sticker]"; top: "SHAKE WELL BEFORE USING // USUAL ADULT DOSE – 1 cc. intramuscularly. // See package insert. // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; right side: "10 CC. Bio. 669 // INFLUENZA // VIRUS VACCINE, // MONOVALENT // Parke, Davis & Co. // Expiration Date and Lot // June 25, 1970 // 988124 B"; left side: "10 CC. Bio. 669 // INFLUENZA // VIRUS VACCINE, // MONOVALENT // Parke, Davis & Co. // Stock 4-669-1-70 // 2 // SFB"; (b) front: "C // 10 CC. Bio. 669 // INFLUENZA VIRUS VACCINE, // MONOVALENT // Each 1 cc. contains 400 CCA // units of A2 ["2" subscr.]/Aichi/2/68 // strain (Hong Kong // Variant) // PARKE, DAVIS & CO. DETROIT, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – // 1 cc. intramuscularly. // See package insert. // SHAKE WELL // BEFORE USING // U.S. Licence No. 1. // Canadian Licence No. 1. // Expiration date and Lot // June 25, 1970 // 988124B"; bottom: "NTI // K // 21 // U.S.A. [embossed]"; top: "FLIP // OFF [embossed]; (c) C // INFLUENZA VIRUS VACCINE, MONOVALENT // Type A2 ["2" subscr.], Aichi Strain (Hong Kong Variant) // PARKE-DAVIS // DESCRIPTION // [text follows] // INDICATIONS // [text follows] // CONTRAINDICATIONS // [text follows] // HL // [text continues from Contraindications] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // PARKE, DAVIS [logo, see sketch on accession sheet] & COMPANY // 121 865350 // K-26-27 DETROIT, MICHIGAN, U.S.A. HL // Issued Nov. 1968"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Comments
Wikipedia "Hong Kong Flu"
Research Facts
Made for the Hong Kong Flu (H3N2) of 1968-1969, which killed approximately one million people worldwide.
Images
Less detail
Dates
1983
circa 1983
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001287 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over the vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is removed, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper l…
  1 image  
Accession Number
000001287 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over the vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is removed, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke-Davis Canada Inc.
Dates
1983
circa 1983
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; blue; black
cardboard: white; blue; black
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "DIN 248991 // Fluogen* // Subvirion Vaccine // Influenza Virus Vaccine. // Trivalent, Types A and B // Dosage – Persons 13 years and older, // a single injection of 0.5 mL; persons // 3 years through 12 years, 2 injections // of 0.5 mL, 4 or more weeks apart; // persons 6 months through 35 months, // 2 injections of 0.25 mL, 4 or more // weeks apart. Inject intramuscularly. // See package insert. // 5 mL // PARKE-DAVIS"; right side: "Contains no less than 45 micrograms // of HA antigen content per 0.5 mL // dose in the recemmended ratio of 15 // µg of HA of the A influenza virus // component represen- // tative of A/Bangkok/1/79 (H3N2) // and 15 µg of HA of the B influenza // virus component representative of // B/Singapore/222/79. The vaccine is / of chick embryo origin. Polysorbate // 80 NF, added during manufacture. // Preservative: 0.01% thimerosal (mer- // cury derivative). Standardized accord- // ing to the 1982-83 NACI and US // PHS requirements. // *Reg. T.M. / M. Enr. Parke, Davis & Company // Parke-Davis Canada Inc. // auth. user / usager aut. // Can. Lic. No. 1 [printed] // (L) 26227 // Exp. JN 1983 [stamped]"; back: front repeated in French; left side: contents as printed on right side repeated in French; "Permis can. n° 1 // Parke-Davis Canada Inc. // Scarborough, Ontario // 266B670 26664"; top: "Store at temperature // between 2° and 8° C // (36° and 46° F) // Freezing destroys // potency. // [above 5 lines repeated in French] // 266B670 26664"; (b) front: "DIN 248991 // Fluogen* // Subvirion Vaccine // Influenza Virus Vaccine, // Trivalent, Types A and B // 5 mL // PARKE-DAVIS"; back: "(L) 26227 // EXP JN 1983 [stamped] // [contents, dosage and storage in English as on box] // Can. Lic. No. 1 // *Reg. T.M. Parke, Davis & Company // PARKE-DAVIS Canada Inc. auth. user // 266H130 26664"; bottom: "W // 37 [embossed]"; top: "FLIP // OFF [embossed]" (c) FLUOGEN* // INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B // Subvirion Vaccine/Immunizing Antigen. // Ether Extracted // DESCRIPTION // [text follows] // CLINICAL PHARMACOLOGY // [text follows] // // 1 // [text continues from Clinical . . .] // INDICATIONS AND USAGE // [text follows] // CONTRAINDICATIONS // [text follows] // 2 // [text continues from Contraindications] // WARNING // [text follows] // PRECAUTIONS // [text follows] // PREGNANCY // [text follows] // ADVERSE REACTIONS // [text follows] // 3 // [text continues from Adverse . . .] // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // *Reg. T.M. / M. Enr. Parke, Davis & Company // Parke-Davis Canada Inc. auth. user / usager aut. // PARKE-DAVIS // 266E940 Parke-Davis Canada Inc., Scarborough, Ontario 26664 // 4 // [French translation occurs alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box somewhat dirty, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail
Dates
1973
circa 1973
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001468 a-b
Description
A cylindrical glass vial (b) inside a cardboard box (a); vial is stopped with a rubber stopper and sealed with a metal cap; a plastic cap covers the metal cap such that when it is pulled off it breaks the seal on the metal cap; vial has a paper label on front and sides and is full of liquid.
  5 images  
Accession Number
000001468 a-b
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
A cylindrical glass vial (b) inside a cardboard box (a); vial is stopped with a rubber stopper and sealed with a metal cap; a plastic cap covers the metal cap such that when it is pulled off it breaks the seal on the metal cap; vial has a paper label on front and sides and is full of liquid.
Number Of Parts
2
Part Names
a - box - Size: Length 5.3 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1973
circa 1973
Date Remarks
Based on expiry date
Material
paper: white; blue
plastic: blue
metal: silver
cardboard: blue; white
rubber: pink
glass: clear
Inscriptions
(a) Front: "5 ML. Bio. 1508 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1972-73 season. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injec- // tions of 0.5 ml. each, given at least two months // apart. See package insert. // [dosage repeated in French] // Prepared from formalin stabilized, zonally cen- // trifuged antigens, ether-extracted from virus // propagated in the extraembryonic fluid of the // chick embryo. // U.S. Patent No. 3,105,012 // Polysorbate 80, U.S.P., added during // manufacture."; back: "5 ML. Bio, 1508 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C // Contains 700 CCA units of A/Aichi/2/68/X-31 (H3N2) // strain (Hong Kong Variant) and 300 CCA units of // B/Massachusetts/1/71 strain in each 0.5-ml. dose. // Stock 4-1508-1-70 // PARKE-DAVIS"; bottom: "Contains 0.01% thimerosal (mercury derivative) // as a preservative. // U.S. Licence No. 1. // Canadian Licence No. 1. // Store at temperature between 2° and 8° C. (36° and 46° F.). // FREEZING DESTROYS POTENCY // SHAKE WELL BEFORE USING // Parke, Davis & Company // Detroit, Michigan 48232 // U.S.A. [printed] // XG YBY [handwritten over printed text]"; right side: "5 ML. Bio. 1508 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] // Dec. 10, 1973 // 900259C [stamped]"; left side: "5 ML. Bio. 1508 // FLUOGEN // Parke, Davis & Co. // Stock 4-1508-1-70 [printed]"; (b) front: "C // 5 ML. Bio. 1508 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains 700 CCA units of A/Aichi/2/68/X-31 (H3N2) // strain (Hong Kong Variant) and 300 CCA units of // B/Massachusetts/1/71 strain in each 0.5-ml. dose. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE–Two // intramuscular injections of 0.5 // ml. each, given at least two // months apart. See package // insert. // Standardized according to the // U.S. Public Health Service // requirements for the 1972-73 season. // U.S. Lic. No. 1. // Canadian Lic. No. 1 // Exp. Date and Lot [printed] // Dec. 10, 1973 // 900259C [stamped]"; bottom: "W // 103 [embossed]"; top: "FLIP // OFF [embossed]"
Permanent Location
Storage Room 0010
0010-A3-7 Row G
Condition Remarks
Box yellowing, dirty, scuffed, torn in two places on the bottom; no apparent problems with vial
Copy Type
Original
Reference Comments
CD #8
Images
Less detail
Dates
1965
circa 1965
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001469 a-c
Description
A cylindrical glass vial (b) inside a cardboard box (a) along with a paper leaflet (c); vial is stopped with a rubber stopper and sealed with a metal cap moulded around the neck and lip; vial has a paper label on front and sides and is full of liquid.
  1 image  
Accession Number
000001469 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
A cylindrical glass vial (b) inside a cardboard box (a) along with a paper leaflet (c); vial is stopped with a rubber stopper and sealed with a metal cap moulded around the neck and lip; vial has a paper label on front and sides and is full of liquid.
Number Of Parts
3
Part Names
a - box - Size: Length 5.3 cm x Width 2.7 cm x Depth 2.7 cm
b - vial - Size: Length 4.2 cm x Diam. 2.3 cm
c - leaflet - Size: Length 17.6 cm x Width 10.0 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1965
circa 1965
Date Remarks
Based on expiry date
Material
paper: white; blue; cream
metal: silver
cardboard: blue; white; black
rubber: grey
glass: clear
Inscriptions
(a) Front: "5 CC. Bio. 666 // RESPROGEN® // Preservative: 0.01% thimerosal. // U.S.Lic. No. 1. Canadian Lic. No. 1. // PARKE, DAVIS & CO., DETROIT, MICH., U.S.A."; top: "An aluminum phosphate adsorbed combination of // Influenza Virus Vaccine, Polyvalent, Types A // and B, 600 CCA units per cc. including 200 CCA units per cc. of Asian strain, (prepared from re- // fined extra-embryonic fluid of the chick embryo // and killed by ultraviolet irradiation) and Adeno- // virus Vaccine (prepared from adenoviruses, // types 3 and 7 in approximately equal propor- // tions, grown in monkey kidney tissue cultures, // inactivated with formaldehyde and supplemen- // tal treatment with ultraviolet irradiation and // beta-propiolactone, as required, and refined by // adsorption on aluminumphosphate"; back: "5 CC. Bio. 666 // ADENOVIRUS AND INFLUENZA // VIRUS VACCINES, COMBINED, // ALUMINUM PHOSPHATE ADSORBED // C // Adenovirus Types 3 and 7 only. // Stock 4-666-1-70 // PARKE, DAVIS & CO. DETROIT, MICH., U.S.A."; bottom: "DOSAGE - Adults, two 1 cc. doses, given // intramuscularly, at least two months apart. // See circular. // SHAKE WELL BEFORE USING // Keep at 2° to 10° C. (35.6° to 50° F.). // FREEZING DESTROYS POTENCY // Expiration Date: [printed] JAN. 5, 1965 [stamped] // Lot No. [printed] 030103A {stamped]"; right side: "5 CC. Bio. 666 // RESPROGEN // Parke, Davis & Co. // Stock 4-666-1-70"; left side: identical to right side; (b) front: "5 CC. Bio. 666 // RESPROGEN® // (ADENOVIRUS AND INFLUENZA VIRUS // VACCINES, COMBINED, // ALUMINUM PHOSPHATE ADSORBED) // Adenovirus Types 3 and 7 only. // U.S. Lic. No. 1. Canadian Lic. No. 1. // PARKE, DAVIS & CO., DETROIT, MICH., U.S.A."; back: "SHAKE WELL // Dose–Adults, two // doses, 1 cc. each // at least two months apart. // See circular. // Exp. Date: [printed] // Jan. 5, 1965 [stamped] // Lot No. [printed] // 030103A [stamped]"; bottom: "K // 6 [embossed]" (c) "RESPROGEN®// (ADENOVIRUS AND INFLUENZA VIRUS VACCINES, // COMBINED, ALUMINUM PHOSPHATE ADSORBED) // [text follows] // ADMINISTRATION AND DOSAGE // [text follows] // BOOSTER OR RECALL DOSE // [text follows] // PRECAUTIONS // [text follows] // REACTIONS // [text follows] // DISCUSSION // [text follows] // STORAGE // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // PARKE, DAVIS [logo, see sketch on accession sheet] & COMPANY // DETROIT, MICHIGAN, U.S.A. // L-58-60 DD // Issued Apr. 1964"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box yellowing, scuffed at edges; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail

11 records – page 1 of 2.